4.7 Article

Understanding chronic inflammatory and neuropathic pain

Journal

ANNALS MEETING REPORTS
Volume 1255, Issue -, Pages 30-44

Publisher

BLACKWELL SCIENCE PUBL
DOI: 10.1111/j.1749-6632.2012.06561.x

Keywords

-

Funding

  1. NYAS Bronze Sponsor Depomed, Inc.
  2. NYAS Academy Friend Sponsors Bristol-Myers Squibb Research and Development
  3. Regeneron Pharmaceuticals, Inc.

Ask authors/readers for more resources

This meeting report highlights the main topics presented at the conference Chronic Inflammatory and Neuropathic Pain, convened jointly by the New York Academy of Sciences, MedImmune, and Grunenthal GmbH, on June 2-3, 2011, with the goal of providing a conducive environment for lively, informed, and synergistic conversation among participants from academia, industry, clinical practice, and government to explore new frontiers in our understanding and treatment of chronic and neuropathic pain. The program included leading and emerging investigators studying the pathophysiological mechanisms underlying neuropathic and chronic pain, and experts in the clinical development of pain therapies. Discussion included novel issues, current challenges, and future directions of basic research in pain and preclinical and clinical development of new therapies for chronic pain.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available